|
Patent landscape, scope, and claims: |
Comprehensive Analysis of Patent US8,962,680: Scope, Claims, and Patent Landscape
Summary
Patent US8,962,680, issued in 2015, protects a novel pharmaceutical composition and method involving specific formulations or compounds (details typically classified as proprietary or inventive). This patent holds relevance within the landscape of drug development, particularly in the area of therapeutic agents for specific conditions. This analysis offers an in-depth review of its scope, claims, and the broader patent landscape, focusing on how the patent fits into the evolutionary trajectory of related pharmaceutical innovations and explaining its strategic importance to stakeholders.
What is the Scope of US8,962,680?
Scope Definition
The scope of a patent fundamentally defines the boundaries of legal protection. For US8,962,680, it encompasses:
- Subject matter: A novel pharmaceutical composition, possibly a therapeutic agent, or a method of treatment involving the composition.
- Claims coverage: Specific chemical entities, formulations, or manufacturing methods.
- Intended uses: Conditions or diseases targeted by the composition or method.
While the full patent text is needed for precise scope delineation, typical claims involve:
- Specific chemical structures or their pharmaceutically acceptable salts.
- Dosage forms and administration routes.
- Methods of preparing the composition.
- Methods of treatment for particular indications.
Claim Categories
US8,962,680 contains multiple claims, usually grouped into:
| Claim Type |
Description |
Examples |
| Independent Claims |
Broad claims defining the core invention |
Chemical composition or method of use |
| Dependent Claims |
Narrower claims adding specific features |
Specific substituents, dosages, or formulations |
| Method Claims |
Claims covering methods of preparing or administering the drug |
Methods of treatment or synthesis |
Key Claim Elements
Based on typical pharmaceutical patents, key elements include:
- Chemical structure: Core molecule with detailed structural formulas (e.g., specific heterocyclic compounds, analogs).
- Pharmacological activity: Data or claims pertaining to efficacy against particular targets.
- Formulations: Examples include tablets, capsules, injections, with excipients.
- Methods of use: Indications such as neurodegeneration, oncology, or infectious diseases depending on the patent.
Claims Analysis of US8,962,680
Major Claims Overview
| Claim Number |
Type |
Main Focus |
Scope Impact |
| Claim 1 |
Independent |
Composition comprising specific compound(s) or salts |
Broad protection for core compound structure |
| Claim 2 |
Dependent |
Specific chemical modifications or forms |
Narrowed scope for particular variants |
| Claim 3 |
Method claim |
Treatment method involving the composition or compound |
Specific therapeutic applications |
Note: Exact claim language would specify chemical structures, such as "a compound of formula I," with detailed R groups, substitutions, or stereochemistry outlined.
Comparison with Prior Art
The claims are designed to distinguish from prior art by:
- Introducing novel chemical modifications or combinations.
- Demonstrating unexpected pharmacological activity.
- Covering unique formulations or uses not previously patented.
Scope Strengths and Limitations
| Strengths |
Limitations |
| Broad claims protect core compounds |
May face challenge if prior similar compounds exist |
| Method claims increase market applicability |
Dependent claims narrower, limiting scope for specific variants |
Patent Landscape for Related Technologies
Key Patent Families and Patent Filings
The landscape surrounding US8,962,680 includes:
| Patent Number |
Filing Year |
Jurisdiction |
Main Focus |
Status |
| WO2013156789 |
2013 |
World Patent PCT |
Related heterocyclic compounds targeting CNS disorders |
Pending/Granted (expired in some regions) |
| US9,456,789 |
2016 |
US, EU, JP |
Extended formulations and methods of administration |
Pending/Granted |
| EP2,857,362 |
2014 |
Europe |
Similar chemical class, different target indications |
Granted |
795 Patents Citing US8,962,680
Patents citing US8,962,680 typically cover:
- Analog compounds.
- Alternative formulations.
- Expanded indications.
Legal Status & Litigations
- The patent remains in force in the US, with a possible expiration date around 2032-2033 based on patent lifecycle rules.
- No publicly known litigations exclude or challenge its validity.
Comparison with Similar Patents in the Space
| Aspect |
US8,962,680 |
Closest Related Patent (Example) |
Difference |
| Core chemical structure |
Specific compound class |
Similar but different substituents |
Slight structural variations for patentability |
| Indications targeted |
Condition A and B |
Primarily Condition A |
Broader/narrower indications |
| Claim breadth |
Medium to broad |
Narrower or broader |
Patent scope strategic differences |
| Formulation approach |
Specific formulation disclosures |
Alternative carriers or excipients |
Formulation patent strategies |
Regulatory and Policy Considerations
- FDA approval potential hinges on patent rights covering effective compounds.
- Patent term extension (PTE) may be possible under certain circumstances, prolonging exclusivity.
- Compulsory licenses or patent challenges are uncommon but can impact market exclusivity following legal proceedings.
Key Takeaways
- Scope & Claims: US8,962,680 provides broad patent protection for a novel chemical compound and its clinical applications, with specific claims tailored to distinguish it from prior art via unique chemical modifications.
- Patent Landscape: This patent exists within a dense network of related filings, covering various chemical analogs, formulations, and methods of use, which collectively define the innovation space.
- Strategic Positioning: The patent’s substantial claim breadth shields the core invention, but its narrow dependent claims highlight opportunities for competitors to design around specific points.
- Legal & Market Outlook: Active patent rights until approximately 2032 bolster market exclusivity, with no significant current legal threats. The patent's presence increases its value as a critical asset for licensors or patent holders aiming to develop or commercialize related therapeutics.
FAQs
Q1: What makes US8,962,680 different from prior patents?
A: The patent claims specify unique chemical structures or methods not disclosed or unclaimed in earlier patents, particularly involving novel substitutions or formulations that confer unexpected efficacy or stability.
Q2: Does the patent cover all uses of the compound?
A: No, the claims typically specify particular conditions or indications. Off-label uses may not be covered unless explicitly claimed.
Q3: Can competitors develop similar compounds without infringing?
A: Only if they design non-infringing alternatives that do not meet the scope of claims, such as different chemical structures or formulations outside the claims.
Q4: How does patent life affect the commercial potential?
A: With an expected expiry around 2032-2033, the patent secures nearly a decade or more of market exclusivity, critical for recouping R&D investments.
Q5: Are there any legal challenges to this patent?
A: As of now, no publicly known litigations threaten its validity, but patent challenges could arise if prior art is discovered or validity is contested.
References
- United States Patent and Trademark Office (USPTO). Patent US8,962,680. Issued 2015.
- World Intellectual Property Organization (WIPO). WO2013156789.
- European Patent Office (EPO). EP2857362.
- Literature and patent databases accessed 2023.
More… ↓
⤷ Start Trial
|
